Carlsmed (CARL) Other Non-Current Assets (2024 - 2026)
Carlsmed's (CARL) quarterly Other Non-Current Assets came in at $253000.0 in Q2 2026, up 153.0% on a YoY basis from $100000.0 in Q2 2025, and up 145.63% quarter-over-quarter from $103000.0 in Q1 2026.
Powered by 
Analysis
Carlsmed (CARL) Other Non-Current Assets (2024 - 2026) Analysis & Trends
Carlsmed (CARL) has reported Other Non-Current Assets for 3 consecutive years, with $253000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Assets rose 153.0% year-over-year to $253000.0; the trailing twelve-month figure through Jun 2026 stood at $253000.0 (up 153.0% YoY), and the FY2025 full-year result was $134000.0, up 34.0% from the prior year.
- Other Non-Current Assets rose to $253000.0 in Q2 2026 per CARL's latest filing, from $103000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $253000.0 in Q2 2026 and bottomed at $100000.0 in Q2 2024.
- Historically, Other Non-Current Assets has averaged $135000.0 across 3 years, with a median of $100000.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Non-Current Assets changed 0.0% in 2025, then surged 153.0% in 2026.
- Over 3 years, Other Non-Current Assets stood at $100000.0 in 2024, then surged by 34.0% to $134000.0 in 2025, then soared by 88.81% to $253000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $253000.0, $103000.0, and $134000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 457.39 Mn |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | 253,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253,000.00 |
| Mar 31, 2026 | 103,000.00 |
| Dec 31, 2025 | 134,000.00 |
| Sep 30, 2025 | 225,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |